^
    Idylla™ EGFR/BRAF+ Assay is a RUO Assay that will be used for detection of the vast majority of actionable mutations in FFPE samples from patients with NSCLC, including a.o. EGFR, BRAF and KRAS G12C.
    Cancer:
    Non Small Cell Lung Cancer
    Gene:
    BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), KRAS (KRAS proto-oncogene GTPase)
    Method:
    PCR